These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17240123)

  • 1. New MultiPEG-conjugated theophylline derivatives: synthesis and pharmacological evaluations.
    Zacchigna M; Di Luca G; Cateni F; Maurich V; Ballico M; Bonora GM; Drioli S
    Eur J Pharm Sci; 2007 Mar; 30(3-4):343-50. PubMed ID: 17240123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic analysis of multi PEG-theophylline conjugates.
    Grassi M; Bonora GM; Drioli S; Cateni F; Zacchigna M
    Comput Biol Chem; 2012 Oct; 40():7-14. PubMed ID: 22922451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of physicochemical and biopharmaceutical properties of theophylline by poly(ethylene glycol) conjugates.
    Zacchigna M; Di Luca G; Cateni F; Zorzet S; Maurich V
    Farmaco; 2003 Dec; 58(12):1307-12. PubMed ID: 14630244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Theophylline semi-solid matrices containing polyethyleneglycols. 3--Mechanism of release].
    Ortigosa AC; Lasserre YJ
    Ann Pharm Fr; 2005 Sep; 63(5):356-61. PubMed ID: 16385786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral sustained delivery of theophylline using in-situ gelation of sodium alginate.
    Miyazaki S; Kubo W; Attwood D
    J Control Release; 2000 Jul; 67(2-3):275-80. PubMed ID: 10825560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of coenzyme Q10 on the pharmacokinetic parameters of theophylline.
    Baskaran R; Shanmugam S; Nagayya-Sriraman S; Kim JH; Jeong TC; Yong CS; Choi HG; Yoo BK
    Arch Pharm Res; 2008 Jul; 31(7):938-44. PubMed ID: 18704339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization and in situ intestinal absorption of different molecular weight scutellarin-PEG conjugates.
    Zhou Q; Jiang X; Li K; Fan X
    Pharmazie; 2006 Aug; 61(8):660-3. PubMed ID: 16964704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEG-metronidazole conjugates: synthesis, in vitro and in vivo properties.
    Bersani C; Berna M; Pasut G; Veronese FM
    Farmaco; 2005 Sep; 60(9):783-8. PubMed ID: 16040031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a new chemoprotective agent, 2-(allylthio)pyrazine, on the pharmacokinetics of intravenous theophylline in rats.
    Han KS; Lee MG
    Int J Pharm; 1999 Jul; 184(2):237-42. PubMed ID: 10387953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation. 5. Theophylline.
    Ammar HO; Ghorab M; El-nahhas SA; Omar SM; Ghorab MM
    Pharmazie; 1996 Jan; 51(1):42-6. PubMed ID: 8999434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of theophylline in obesity.
    Zahorska-Markiewicz B; Waluga M; Zieliñski M; Klin M
    Int J Clin Pharmacol Ther; 1996 Sep; 34(9):393-5. PubMed ID: 8880289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of theophylline-polyrotaxane conjugates and their drug release via supramolecular dissociation.
    Ooya T; Yui N
    J Control Release; 1999 Apr; 58(3):251-69. PubMed ID: 10099151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic and pharmacokinetic characterization of poly(ethylene glycol) conjugation to met-enkephalin analog [D-Pen2, D-Pen5]-enkephalin (DPDPE).
    Witt KA; Huber JD; Egleton RD; Roberts MJ; Bentley MD; Guo L; Wei H; Yamamura HI; Davis TP
    J Pharmacol Exp Ther; 2001 Aug; 298(2):848-56. PubMed ID: 11454951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro efficacy of acid-sensitive poly(ethylene glycol) paclitaxel conjugates.
    Rodrigues P; Scheuermann K; Stockmar C; Maier G; Fiebig H; Unger C; Mulhaupt R; Kratz F
    Bioorg Med Chem Lett; 2003 Feb; 13(3):355-60. PubMed ID: 12882225
    [No Abstract]   [Full Text] [Related]  

  • 16. Bronchospasmolytic activity and toxicity modelling of theophylline derivatives by a microcomputer based method.
    Mekenyan O; Stoyanova G; Kamenska V; Davkov D; Pejkov P
    Arzneimittelforschung; 1993 Dec; 43(12):1341-50. PubMed ID: 8141824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-activity relationship study of some 7-substituted theophyllines.
    Türker L; Akgün H; Balkan A
    Arzneimittelforschung; 1998 Jan; 48(1):39-42. PubMed ID: 9522029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Semisolid theophylline matrices containing polyethyleneglycols. 2. Determination of molecular mass of the binary PEG].
    Ortigosa CA; Lasserre YJ
    Ann Pharm Fr; 2004 Sep; 62(5):348-53. PubMed ID: 15314583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polymeric prodrug of 5-fluorouracil-1-acetic acid using a multi-hydroxyl polyethylene glycol derivative as the drug carrier.
    Li M; Liang Z; Sun X; Gong T; Zhang Z
    PLoS One; 2014; 9(11):e112888. PubMed ID: 25389968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel monodisperse PEG-dendrons as new tools for targeted drug delivery: synthesis, characterization and cellular uptake.
    Berna M; Dalzoppo D; Pasut G; Manunta M; Izzo L; Jones AT; Duncan R; Veronese FM
    Biomacromolecules; 2006 Jan; 7(1):146-53. PubMed ID: 16398509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.